Phreesia (PHR) Moves 5.6% Higher: Will This Strength Last?

Company Overview - Phreesia (PHR) shares increased by 5.6% to $30.01 in the last trading session, with a higher-than-average trading volume, compared to a 4.9% gain over the past four weeks [1] - The company is recognized for its leadership, as Sally Thayer, Vice President of Product Management, was named to The Software Report's list of the Top 50 Women Leaders in Software of 2024, marking the seventh consecutive year a female leader from Phreesia has received this honor [2] Financial Performance - Phreesia is expected to report a quarterly loss of$ 0.19 per share, reflecting a year-over-year improvement of 66.1%, with anticipated revenues of $108.91 million, up 14.6% from the same quarter last year [3] - The consensus EPS estimate for the upcoming quarter has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [4] Industry Context - Phreesia operates within the Zacks Medical Info Systems industry, which includes other companies like Pulmonx Corporation (LUNG), whose shares also saw a 5.3% increase to$ 7.38 in the last trading session, with a 4.3% return over the past month [4] - Pulmonx's consensus EPS estimate for its upcoming report has remained unchanged at -$0.43, representing a year-over-year change of -19.4% [5]